1. Home
  2. CVAC vs LQDT Comparison

CVAC vs LQDT Comparison

Compare CVAC & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • LQDT
  • Stock Information
  • Founded
  • CVAC 2000
  • LQDT 1999
  • Country
  • CVAC Germany
  • LQDT United States
  • Employees
  • CVAC N/A
  • LQDT N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • LQDT Catalog/Specialty Distribution
  • Sector
  • CVAC Health Care
  • LQDT Consumer Discretionary
  • Exchange
  • CVAC Nasdaq
  • LQDT Nasdaq
  • Market Cap
  • CVAC 764.4M
  • LQDT 773.6M
  • IPO Year
  • CVAC 2020
  • LQDT 2006
  • Fundamental
  • Price
  • CVAC $5.44
  • LQDT $23.31
  • Analyst Decision
  • CVAC Buy
  • LQDT Strong Buy
  • Analyst Count
  • CVAC 3
  • LQDT 2
  • Target Price
  • CVAC $9.00
  • LQDT $38.50
  • AVG Volume (30 Days)
  • CVAC 2.1M
  • LQDT 239.1K
  • Earning Date
  • CVAC 08-14-2025
  • LQDT 08-07-2025
  • Dividend Yield
  • CVAC N/A
  • LQDT N/A
  • EPS Growth
  • CVAC N/A
  • LQDT 23.09
  • EPS
  • CVAC 0.87
  • LQDT 0.79
  • Revenue
  • CVAC $566,039,775.00
  • LQDT $439,246,000.00
  • Revenue This Year
  • CVAC N/A
  • LQDT $35.02
  • Revenue Next Year
  • CVAC $24.04
  • LQDT $9.90
  • P/E Ratio
  • CVAC $6.34
  • LQDT $29.48
  • Revenue Growth
  • CVAC 787.60
  • LQDT 35.78
  • 52 Week Low
  • CVAC $2.37
  • LQDT $18.94
  • 52 Week High
  • CVAC $5.72
  • LQDT $39.72
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 68.03
  • LQDT 33.51
  • Support Level
  • CVAC $4.07
  • LQDT $23.36
  • Resistance Level
  • CVAC $5.58
  • LQDT $23.92
  • Average True Range (ATR)
  • CVAC 0.20
  • LQDT 0.65
  • MACD
  • CVAC 0.07
  • LQDT 0.13
  • Stochastic Oscillator
  • CVAC 83.08
  • LQDT 20.56

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

Share on Social Networks: